1. Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings. (30th September 2022) Authors: Darlow, Christopher A; McEntee, Laura; Johnson, Adam; Farrington, Nicola; Unsworth, Jennifer; Jimenez-Valverde, Ana; Jagota, Bhavana; Kolamunnage-Dona, Ruwanthi; Da Costa, Renata M A; Ellis, Sally; Franceschi, François; Sharland, Mike; Neely, Michael; Piddock, Laura; Das, Shampa; Hope, William Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 12(2022) Page Start: 3349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups. Issue 2 (28th September 2018) Authors: Li, Jianguo; Lovern, Mark; Green, Michelle L.; Chiu, Joannellyn; Zhou, Diansong; Comisar, Craig; Xiong, Yuan; Hing, Jeremy; MacPherson, Merran; Wright, James G.; Riccobene, Todd; Carrothers, Timothy J.; Das, Shampa Journal: Clinical and translational science Issue: Volume 12:Issue 2(2019) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing. (June 2022) Authors: Gatermann, Sören; Das, Shampa; Dubreuil, Luc; Giske, Christian G.; Kahlmeter, Gunnar; Lina, Gerard; Lindemann, Christoffer; MacGowan, Alasdair; Meletiadis, Joseph; Rossolini, Gian Maria; Turnidge, John; Cantón, Rafael Journal: Clinical microbiology and infection Issue: Volume 28:Number 6(2022) Page Start: 764 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance. (15th February 2022) Authors: Darlow, Christopher A.; Farrington, Nicola; Johnson, Adam; McEntee, Laura; Unsworth, Jennifer; Jimenez-Valverde, Ana; Kolamunnage-Dona, Ruwanthi; Da Costa, Renata M A; Ellis, Sally; Franceschi, François; Sharland, Mike; Neely, Michael; Piddock, Laura J. V.; Das, Shampa; Hope, William Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 5(2022) Page Start: 1334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase 1 Study Assessing the Pharmacokinetic Profile and Safety of Avibactam in Patients With Renal Impairment. (27th September 2016) Authors: Merdjan, Henri; Tarral, Antoine; Das, Shampa; Li, Jianguo Journal: Journal of clinical pharmacology Issue: Volume 57:Number 2(2017) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Population Pharmacokinetic Modeling and Probability of Target Attainment Analyses in Asian Patients With Community‐Acquired Pneumonia Treated With Ceftaroline Fosamil. Issue 5 (1st May 2019) Authors: Li, Jianguo; Das, Shampa; Zhou, Diansong; Al‐Huniti, Nidal Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 5(2019) Page Start: 682 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community‐Acquired Bacterial Pneumonia. (27th September 2016) Authors: Riccobene, Todd A.; Khariton, Tatiana; Knebel, William; Das, Shampa; Li, James; Jandourek, Alena; Carrothers, Timothy J.; Bradley, John S. Journal: Journal of clinical pharmacology Issue: Volume 57:Number 3(2017) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Randomized pharmacokinetic and drug–drug interaction studies of ceftazidime, avibactam, and metronidazole in healthy subjects. Issue 5 (25th August 2015) Authors: Das, Shampa; Li, Jianguo; Armstrong, Jon; Learoyd, Maria; Edeki, Timi Journal: Pharmacology research & perspectives Issue: Volume 3:Issue 5(2015:Oct) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Randomized, placebo‐controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime–avibactam or ceftaroline fosamil–avibactam. (22nd October 2013) Authors: Das, Shampa; Armstrong, Jon; Mathews, David; Li, Jianguo; Edeki, Timi Journal: Journal of clinical pharmacology Issue: Volume 54:Number 3(2014:Mar.) Page Start: 331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility. (December 2020) Authors: Kahlmeter, Gunnar; Cantón, Rafael; Giske, Christian G.; Turnidge, John; Giske, Christian G.; Turnidge, John; Cantón, Rafael; Kahlmeter, Gunnar; Das, Shampa; Gatermann, Sören; Lina, Gerard; Lindemann, Christoffer; MacGowan, Alasdair; Meletiadis, Joseph; Rossolini, Gian-Maria; Sampaio, Jorge Journal: Clinical microbiology and infection Issue: Volume 26:Number 12(2020) Page Start: 1692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗